HOOKIPA Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HOOK research report →
About the company
HOOKIPA Pharma Inc. , a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer.
- CEO
- Malte Peters
- IPO
- 2019
- Employees
- 82
- HQ
- New York, NY, US
Price Chart
- Market Cap
- $14.40M
- P/E
- -0.32
- P/S
- 1.42
- P/B
- 0.51
- EV/EBITDA
- 0.47
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -453.11%
- Net Margin
- -415.28%
- ROE
- -110.98%
- ROIC
- -114.60%
- Revenue
- $9.70M · -77.93%
- Net Income
- $-13,837,000 · 68.19%
- EPS
- $-1.09 · 68.59%
- Op Income
- $-36,572,000
- FCF YoY
- 85.07%
- 52W High
- $1.55
- 52W Low
- $0.81
- 50D MA
- $1.15
- 200D MA
- $1.00
- Beta
- 0.77
- Avg Volume
- 11.96K
Get TickerSpark's AI analysis on HOOK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 25 | Peters Malte | sell | 25,172 |
| Jul 22, 25 | Peters Malte | sell | 29,176 |
| Jul 22, 25 | Coelho Mary Theresa | sell | 13,609 |
| Jul 22, 24 | Coelho Mary Theresa | other | 69,875 |
| Jul 22, 24 | Peters Malte | other | 108,695 |
| Jul 22, 24 | Cassidy Sean A | other | 9,800 |
| Jul 22, 24 | Cassidy Sean A | other | 0 |
| Jun 17, 24 | Peters Malte | other | 49,000 |
| Jun 17, 24 | van de Winkel Jan | other | 98,000 |
| Jun 17, 24 | Kaufman David Ross | other | 49,000 |
Our HOOK coverage
Recent articles, reports, and earnings notes.
No research on HOOK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HOOK report →Similar companies
Peers in the same neighborhood.